Delivery Order SPE2DB24D3014-SPE2DB25FKUAZ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,970.66 on April 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price, competitively awarded contract represents a non-set-aside procurement with an ultimate completion date of April 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $13,360.62 to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 mL syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $58,226.32 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, issued on July 31, 2025, represents a non-set-aside award made through open competition. The work will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes, with a ceiling value of $3,893.84. The contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,358.35 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical supply vehicle that runs through December 2026. The delivery order is scheduled for completion by July 28, 2025, with performance...
- The Defense Logistics Agency awarded a $13,703.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $4,064.07 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ml syringes, with completion targeted for April 24, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUAZDelivery Order
The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor specializing in brand-name and generic medications, vaccines, and medical supplies. The company's extensive portfolio of delivery orders with the Defense Logistics Agency demonstrates its capability to meet competitive federal procurement requirements across multiple therapeutic domains. This specific award for Vaxneuvance syringes supports the Defense Health Agency's broader medical supply chain and reflects the contractor's ongoing role as a primary pharmaceutical vendor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 7/21/25 |